Eric Vieira

1.9k total citations
25 papers, 1.4k citations indexed

About

Eric Vieira is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Eric Vieira has authored 25 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Cellular and Molecular Neuroscience and 6 papers in Organic Chemistry. Recurrent topics in Eric Vieira's work include Neuroscience and Neuropharmacology Research (13 papers), Receptor Mechanisms and Signaling (9 papers) and Synthetic Organic Chemistry Methods (5 papers). Eric Vieira is often cited by papers focused on Neuroscience and Neuropharmacology Research (13 papers), Receptor Mechanisms and Signaling (9 papers) and Synthetic Organic Chemistry Methods (5 papers). Eric Vieira collaborates with scholars based in Switzerland, France and United States. Eric Vieira's co-authors include Pierre Vogel, Vincent Mutel, Jürgen Wichmann, Frédéric Knoflach, Synèse Jolidon, Pari Malherbe, Eric Prinssen, Will Spooren, Richard H. Porter and Sabine Kolczewski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Development.

In The Last Decade

Eric Vieira

25 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Vieira Switzerland 18 825 542 430 99 92 25 1.4k
Jon E. Hawkinson United States 25 856 1.0× 885 1.6× 353 0.8× 137 1.4× 33 0.4× 74 1.8k
Darren W. Engers United States 26 1.0k 1.3× 831 1.5× 265 0.6× 86 0.9× 46 0.5× 73 1.6k
Wha Bin Im United States 28 1.4k 1.7× 771 1.4× 435 1.0× 68 0.7× 56 0.6× 85 2.3k
Stephen R. Fletcher United States 20 941 1.1× 323 0.6× 640 1.5× 81 0.8× 49 0.5× 38 1.8k
F. Gualtieri Italy 18 645 0.8× 390 0.7× 177 0.4× 108 1.1× 21 0.2× 68 1.5k
Mark W. Dudley United States 21 524 0.6× 365 0.7× 362 0.8× 42 0.4× 78 0.8× 38 1.3k
Kyle A. Emmitte United States 29 1.4k 1.7× 1.0k 1.9× 550 1.3× 110 1.1× 18 0.2× 68 2.2k
David E. Nichols United States 20 1.6k 2.0× 1.7k 3.1× 341 0.8× 115 1.2× 29 0.3× 50 2.5k
Michael A. Letavic United States 31 672 0.8× 184 0.3× 662 1.5× 182 1.8× 31 0.3× 69 2.3k
Victor I. Ilyin United States 22 699 0.8× 481 0.9× 141 0.3× 36 0.4× 24 0.3× 35 1.1k

Countries citing papers authored by Eric Vieira

Since Specialization
Citations

This map shows the geographic impact of Eric Vieira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Vieira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Vieira more than expected).

Fields of papers citing papers by Eric Vieira

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Vieira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Vieira. The network helps show where Eric Vieira may publish in the future.

Co-authorship network of co-authors of Eric Vieira

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Vieira. A scholar is included among the top collaborators of Eric Vieira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Vieira. Eric Vieira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Santolini, Ines, Luana Lionetto, Maurizio Simmaco, et al.. (2014). Head-to head comparison of mGlu1 and mGlu5 receptor activation in chronic treatment of absence epilepsy in WAG/Rij rats. Neuropharmacology. 85. 91–103. 27 indexed citations
3.
Lindemann, Lothar, Georg Jaeschke, Aubin Michalon, et al.. (2011). CTEP: A Novel, Potent, Long-Acting, and Orally Bioavailable Metabotropic Glutamate Receptor 5 Inhibitor. Journal of Pharmacology and Experimental Therapeutics. 339(2). 474–486. 91 indexed citations
4.
Zamparini, Andrea L., Marie Y. Davis, Colin D. Malone, et al.. (2011). Vreteno, a gonad-specific protein, is essential for germline development and primary piRNA biogenesis inDrosophila. Development. 138(18). 4039–4050. 97 indexed citations
5.
Vieira, Eric, Jörg Huwyler, Synèse Jolidon, et al.. (2009). Fluorinated 9H-xanthene-9-carboxylic acid oxazol-2-yl-amides as potent, orally available mGlu1 receptor enhancers. Bioorganic & Medicinal Chemistry Letters. 19(6). 1666–1669. 36 indexed citations
7.
8.
Ceccarelli, Simona, Georg Jaeschke, Bernd Buettelmann, et al.. (2006). Rational design, synthesis, and structure–activity relationship of benzoxazolones: New potent mglu5 receptor antagonists based on the fenobam structure. Bioorganic & Medicinal Chemistry Letters. 17(5). 1302–1306. 20 indexed citations
9.
Jaeschke, Georg, Richard H. Porter, Bernd Büttelmann, et al.. (2006). Synthesis and biological evaluation of fenobam analogs as mGlu5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(5). 1307–1311. 14 indexed citations
10.
Büttelmann, Bernd, Jens‐Uwe Peters, Simona Ceccarelli, et al.. (2006). Arylmethoxypyridines as novel, potent and orally active mGlu5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 16(7). 1892–1897. 8 indexed citations
11.
Vieira, Eric, Jörg Huwyler, Synèse Jolidon, et al.. (2005). 9H-Xanthene-9-carboxylic acid [1,2,4]oxadiazol-3-yl- and (2H-tetrazol-5-yl)-amides as potent, orally available mGlu1 receptor enhancers. Bioorganic & Medicinal Chemistry Letters. 15(20). 4628–4631. 82 indexed citations
12.
Porter, Richard H., Georg Jaeschke, Will Spooren, et al.. (2005). Fenobam: A Clinically Validated Nonbenzodiazepine Anxiolytic Is a Potent, Selective, and Noncompetitive mGlu5 Receptor Antagonist with Inverse Agonist Activity. Journal of Pharmacology and Experimental Therapeutics. 315(2). 711–721. 246 indexed citations
13.
Wichmann, Jürgen, Konrad Bleicher, Eric Vieira, et al.. (2002). Alkyl diphenylacetyl, 9H-xanthene- and 9H-thioxanthene-carbonyl carbamates as positive allosteric modulators of mGlu1 receptors. Il Farmaco. 57(12). 989–992. 25 indexed citations
15.
Gu, Chunyan, et al.. (2000). Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 protooncogenes. Oncogene. 19(10). 1334–1345. 19 indexed citations
16.
Vieira, Eric, Alfred Binggeli, Volker Breu, et al.. (1999). Substituted piperidines - highly potent renin inhibitors due to induced fit adaptation of the active site. Bioorganic & Medicinal Chemistry Letters. 9(10). 1397–1402. 79 indexed citations
17.
Güller, Rolf, Alfred Binggeli, Volker Breu, et al.. (1999). Piperidine-renin inhibitors compounds with improved physicochemical properties. Bioorganic & Medicinal Chemistry Letters. 9(10). 1403–1408. 52 indexed citations
18.
Wagner, Jürgen, Eric Vieira, & Pierre Vogel. (1988). Enantiomerically pure 7‐oxabicylo[2.2.1]hept‐5‐en‐zyl derivatives as synthetic intermediates. Part III. Total synthesis of D‐ and L‐ribose derivatives. Helvetica Chimica Acta. 71(3). 624–630. 67 indexed citations
19.
Vieira, Eric, et al.. (1987). Synthesis of wyerone benzene analogue, its epoxide derivative and other a-alkynylcarbonyl compounds. Química Nova. 10(3). 189–193. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026